In cancer cells, the endogenous inhibitors of the STAT3 signaling pathway undergo downregulation, which mediates the enhanced proliferation and malignancy of cancer cells (Figure 1) [45,46,47,48]. This evidence concerns the gene STAT3 and cancer.